Take a look at the evolution of aspirin used in modern disease prevention to gain perspective on how more recent developments may affect your practice.
Poor Cardiovascular-Kidney-Metabolic Health “Widespread” among US Adults, According to New Study
Results also showed that older adults, men, and Black adults face an increased risk of advanced stages of CKM syndrome.
Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care
Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.
SGLT2 Inhibitor Use Improves Quality of Life, Functional Capacity in Patients with Heart Failure
Patients with HF who received SGLT2i therapy had significant improvement in functional capacity and QOL, regardless of sex, diabetes status, or ejection fraction, report researchers.
Primary Viewpoints Episode 4: Lp(a): The Next CVD Target?
Patrick Moriarty, MD, from the University of Kansas Medical Center, discusses the role of Lp(a) as a risk factor for cardiovascular disease and the phase 3 trials of a potential treatment.
Atrial Fibrillation May be More Common in Younger Adults than Previously Thought: Daily Dose
Your daily dose of the clinical news you may have missed.
Cardiovascular-Kidney-Metabolic (CKM) Syndrome Affects Nearly All US Adults
The majority of the US adult population meets criteria for subclinical CKM syndrome indicating "an urgent need for population-wide risk reduction measures."